Effect of Bosentan® in Candidate to Heart Transplantation with Pulmonary Hypertension Secondary to Congestive Heart Failure

被引：0
|
作者：
Maccherini, M. [1 ]
Tsioulpas, C. [1 ]
Bernazzali, S. [1 ]
Diciolla, F. [1 ]
Borrelli, E. [1 ]
机构：
[1] Univ Siena, Santa Maria Scotte Hosp, I-53100 Siena, Italy
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2009年 / 28卷 / 02期
关键词：
D O I：
10.1016/j.healun.2008.11.584
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
577
引用
收藏
页码：S266 / S266
页数：1
相关论文
共 50 条
  • [31] Bosentan therapy in patients with pulmonary hypertension secondary to congenital heart disease (Eisenmenger physiology)
    D'Alto, M
    Sarubbi, B
    Vizza, CD
    Romeo, E
    Santoro, G
    Argiento, P
    Russo, MG
    Calabrò, R
    CHEST, 2005, 128 (04) : 366S - 366S
  • [32] Effects of Bosentan in Patients Considered Ineligible for Heart Transplantation Because of Severe Pulmonary Hypertension
    Tatier, I.
    Farrero, M.
    Cardona, M.
    Pensa, D.
    Castel, A.
    Perez-Villa, F.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S53 - S53
  • [33] Slidenafil or Bosentan in Patients Considered Inelegible Heart Transplantation Because of Severe Pulmonary Hypertension
    Farrero, Maria
    Villa, Felix Perez
    Arias, Adrian
    Castel, Maria Angeles
    Sionis, Alessandro
    Roig, Eulalia
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A180 - A180
  • [34] Effect of ETA receptor antagonist on pulmonary hypertension and vascular reactivity in rats with congestive heart failure
    Lucas, M
    Jasmin, JF
    Dupuis, J
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2001, 14 (04) : 307 - 314
  • [35] Sildenafil or Bosentan in Patients Considered Inelegible for Heart Transplantation Because of Severe Pulmonary Hypertension
    Farrero, M.
    Perez-Villa, F.
    Arias, A.
    Stonis, A.
    Castel, A.
    Roig, E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S265 - S265
  • [36] Benefitial Effects on Hemodynamics and Clinical Outcome in Heart Failure Patients with Pulmonary Hypertension Awaiting Cardiac Transplantation Treated with Bosentan
    Schulz, U.
    Hefke, T. K.
    Zittermann, A.
    Fuchs, U.
    Gummert, J. F.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S80 - S80
  • [37] Effect of bosentan in children with pulmonary arterial hypertension associated with congenital heart disease
    Rosenzweig, E. Berman
    Ivy, D. D.
    Doran, A. K.
    Claussen, L. R.
    Yung, D.
    Widlitz, A. C.
    Abman, S.
    Barst, R. J.
    EUROPEAN HEART JOURNAL, 2006, 27 : 617 - 617
  • [38] Effect of heart transplantation on impaired peripheral microvascular perfusion and reactivity in congestive heart failure
    Andreassen, AK
    Kirkeboen, KA
    Gullestad, L
    Simonsen, S
    Kvernebo, K
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1998, 65 (01) : 33 - 40
  • [39] Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: Analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database
    Khush, Kiran K.
    Tasissa, Gudaye
    Butler, Javed
    McGlothlin, Dana
    De Marco, Teresa
    AMERICAN HEART JOURNAL, 2009, 157 (06) : 1026 - 1034
  • [40] Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction
    Thenappan, Thenappan
    Prins, Kurt W.
    Cogswell, Rebecca
    Shah, Sanjiv J.
    CANADIAN JOURNAL OF CARDIOLOGY, 2015, 31 (04) : 430 - 439
12345